AMNEAL PHARMACEUTICALS, INC. Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders of $56.70 million for the 12-month period ending 2023-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Shareholders' Equity
us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders · last filed 2026-02-27
- AMNEAL PHARMACEUTICALS, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2023-12-31 was -$2.00M, a 353.16% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2023-09-30 was $10.60M, a 327.42% increase year-over-year.
- AMNEAL PHARMACEUTICALS, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2023-06-30 was $21.20M, a 633.56% increase year-over-year.
- AMNEAL PHARMACEUTICALS, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for the quarter ending 2023-03-31 was $26.80M, a 503.60% increase year-over-year.
- AMNEAL PHARMACEUTICALS, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2023 was $56.70M, a 434.91% increase from fiscal 2022.
- AMNEAL PHARMACEUTICALS, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2022 was $10.60M, a 80.19% decline from fiscal 2021.
- AMNEAL PHARMACEUTICALS, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2021 was $53.50M, a 1810.71% increase from fiscal 2020.
- AMNEAL PHARMACEUTICALS, INC. noncontrolling interest, decrease from distributions to noncontrolling interest holders for fiscal 2020 was $2.80M, a 2700.00% increase from fiscal 2019.
| Period end | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 3 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 3 month as first filed | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 5 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 6 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 6 month as first filed | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 9 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 9 month as first filed | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 12 month | Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $8.60M derived: sum of 2 quarters · filed 2026-02-27 | $29.80M derived: sum of 3 quarters · filed 2026-02-27 | $56.70M 10-K · filed 2026-02-27 | |||||
| 2023-09-30 | $10.60M 10-Q · filed 2024-11-12 | $10.64M 10-Q · filed 2023-11-09 | $31.80M derived: sum of 2 quarters · filed 2024-11-12 | $58.70M 10-Q · filed 2024-11-12 | $58.65M 10-Q · filed 2023-11-09 | $59.39M derived: sum of 4 quarters · filed 2025-02-28 | |||
| 2023-06-30 | $21.20M 10-Q · filed 2024-08-09 | $48.00M 10-Q · filed 2024-08-09 | $48.01M 10-Q · filed 2023-08-08 | $48.79M derived: sum of 3 quarters · filed 2025-02-28 | $51.27M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $26.80M 10-Q · filed 2024-05-08 | $26.81M 10-Q · filed 2023-05-09 | $27.59M derived: sum of 2 quarters · filed 2025-02-28 | $30.07M derived: sum of 3 quarters · filed 2025-02-28 | $32.96M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $790.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $3.27M derived: sum of 2 quarters · filed 2025-02-28 | $6.16M derived: sum of 3 quarters · filed 2025-02-28 | $10.60M 10-K · filed 2025-02-28 | |||||
| 2022-09-30 | $2.48M 10-Q · filed 2023-11-09 | $2.50M 10-Q · filed 2022-11-07 | $5.37M derived: sum of 2 quarters · filed 2023-11-09 | $9.81M 10-Q · filed 2023-11-09 | $9.80M 10-Q · filed 2022-11-07 | $28.81M derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2022-06-30 | $2.89M 10-Q · filed 2023-08-08 | $2.90M 10-Q · filed 2022-08-08 | $7.33M 10-Q · filed 2023-08-08 | $7.30M 10-Q · filed 2022-08-08 | $26.33M derived: sum of 3 quarters · filed 2024-03-14 | $34.93M derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2022-03-31 | $4.44M 10-Q · filed 2023-05-09 | $4.40M 10-Q · filed 2022-05-06 | $23.44M derived: sum of 2 quarters · filed 2024-03-14 | $32.04M derived: sum of 3 quarters · filed 2024-03-14 | $48.64M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2021-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $27.60M derived: sum of 2 quarters · filed 2024-03-14 | $44.20M derived: sum of 3 quarters · filed 2024-03-14 | $53.50M 10-K · filed 2024-03-14 | $53.00M 10-K · filed 2022-03-01 | ||||
| 2021-09-30 | $8.60M 10-Q · filed 2022-11-07 | $9.00M 10-Q · filed 2021-11-08 | $25.20M derived: sum of 2 quarters · filed 2022-11-07 | $34.50M 10-Q · filed 2022-11-07 | $34.00M 10-Q · filed 2021-11-08 | $36.20M derived: sum of 4 quarters · filed 2023-03-03 | |||
| 2021-06-30 | $16.60M 10-Q · filed 2022-08-08 | $17.00M 10-Q · filed 2021-08-09 | $25.90M 10-Q · filed 2022-08-08 | $26.00M 10-Q · filed 2021-08-09 | $27.60M derived: sum of 3 quarters · filed 2023-03-03 | $27.60M derived: sum of 4 quarters · filed 2023-03-03 | |||
| 2021-03-31 | $9.20M 10-Q · filed 2022-05-06 | $9.00M 10-Q · filed 2021-05-07 | $11.00M derived: sum of 2 quarters · filed 2023-03-03 | $11.00M derived: sum of 3 quarters · filed 2023-03-03 | $12.00M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2020-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $1.80M derived: sum of 2 quarters · filed 2023-03-03 | $2.80M derived: sum of 3 quarters · filed 2023-03-03 | $2.80M 10-K · filed 2023-03-03 | $3.00M 10-K · filed 2021-03-01 | ||||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-08 | $1.00M derived: sum of 2 quarters · filed 2021-11-08 | $1.00M 10-Q · filed 2021-11-08 | $1.00M derived: sum of 4 quarters · filed 2022-03-01 | |||||
| 2020-06-30 | $1.00M 10-Q · filed 2021-08-09 | $1.00M 10-Q · filed 2021-08-09 | $1.00M derived: sum of 3 quarters · filed 2022-03-01 | $1.00M derived: sum of 4 quarters · filed 2022-03-01 | |||||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-07 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $0.00 derived: sum of 4 quarters · filed 2022-03-01 | |||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $0.00 derived: sum of 2 quarters · filed 2022-03-01 | $0.00 derived: sum of 3 quarters · filed 2022-03-01 | $100.00K 10-K · filed 2022-03-01 | $0.00 10-K · filed 2020-03-02 | ||||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-06 | $0.00 derived: sum of 2 quarters · filed 2020-11-06 | $100.00K 10-Q · filed 2020-11-06 | $13.50M derived: sum of 4 quarters · filed 2020-11-06 | |||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | $13.50M derived: sum of 3 quarters · filed 2020-08-06 | $49.00M derived: sum of 4 quarters · filed 2020-08-06 | |||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 | $13.50M derived: sum of 2 quarters · filed 2020-05-11 | $49.00M derived: sum of 3 quarters · filed 2020-05-11 | ||||||
| 2018-12-31 | $13.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $49.00M derived: sum of 2 quarters · filed 2020-03-02 | $49.00M 10-K · filed 2020-03-02 | ||||||
| 2018-09-30 | $35.50M 10-Q · filed 2018-11-07 | $35.54M 10-Q · filed 2018-11-07 | $35.50M 10-Q · filed 2018-11-07 | ||||||
| 2017-12-31 | $865.00K 10-K · filed 2019-03-01 | ||||||||
| 2016-12-31 | $973.00K 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |